Pharmacokinetics of Zanamivir After Intravenous, Oral, Inhaled or Intranasal Administration to Healthy Volunteers

Rational design of potent sialidase-based inhibitors of influenza virus replication

Mark von Itzstein, Wen‐Yang Wu, Gaik B. Kok et al. · Nature · 1993 · 1.9K citations

Pharmacy, Medicinal Chemistry, Molecular Biology +16

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

Jacqueline M. Woods, Richard C. Bethell, Jonathon Alexis Coates et al. · Antimicrobial Agents and Chemotherapy · 1993 · 312 citations

Life Sciences, Microbiology, Pharmacology +12

Safety and Efficacy of Intravenous Zanamivir in Preventing Experimental Human Influenza A Virus Infection

David P. Calfee, Amy Peng, Lindsey Cass et al. · Antimicrobial Agents and Chemotherapy · 1999 · 135 citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

Pharmacoscintigraphic Evaluation of Lung Deposition of Inhaled Zanamivir in Healthy Volunteers

Lindsey Cass, Joanne Brown, Matthew Pickford et al. · Clinical Pharmacokinetics · 1999 · 132 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Estimation of nasal epithelial lining fluid using urea as a marker

Helen C. Kaulbach, Martha V. White, Barbara Hahn et al. · Journal of Allergy and Clinical Immunology · 1993 · 75 citations

Medicine, Anatomy, Otolaryngology +8